FEATURE STORY Pfizer adds 500MUS$ to gene therapy manufacturing plant GENE THERAPY AAV-ie enables safe and efficient gene transfer to inner ear cells. Recent advances in the targeting of systemically administered non-viral gene delivery systems DISRUPTIVE TECHNOLOGIES Efficient electroporation of neuronal cells using synthetic oligonucleotides Potential applications of nanoparticles for…..
Pfizer invests $500 million to advance state-of-the-art gene therapy facility Pfizer announced an additional half billion dollar investment for the construction of its state-of-the-art gene therapy manufacturing facility in Sanford, North Carolina. This facility is anticipated to support Pfizer’s continuing investment in gene therapy research and development, similar to Pfizer’s…..
AskBio Strengthens its Gene Therapy Technology Portfolio Asklepios Biopharmaceutical (AskBio), a US clinical-stage gene therapy platform company dedicated to rare genetic disorders, is currently expanding its technological capabilities. This AAV gene therapy company has now acquired Synpromics, a UK-based leader in gene control synthetic promoter technology, bioinformatics and intelligent data-driven design…..